Filtros de búsqueda

Lista de obras de Therese Törngren

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

artículo científico publicado en 2010

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

artículo científico publicado en 2020

Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study

artículo científico publicado en 2010

Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication

artículo científico

Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility

artículo científico

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

artículo científico publicado en 2019

Molecular profiling reveals low- and high-grade forms of primary melanoma

artículo científico publicado en 2012

Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.

artículo científico publicado en 2015

Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma

scientific article published on 23 May 2016

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

artículo científico publicado en 2017

Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study

artículo científico publicado en 2010

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda